- Investopedia•7 hours ago
JP Morgan cut Teva price target and rating today. What are the options to spur growth in the coming quarters?
- Insider Monkey•yesterday
Patients with severe pain that demands long-term, around-the-clock treatment now have a new medication to try. They will now be able to use Vantreal ER (hydrocodone bitartrate), which has gained the approval of the US Food and Drug Administration (FDA). The drug from Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is suitable for daily management of […]
Teva Pharmaceutical Industries Ltd. (TEVA) announced that the FDA has approved Vantrela ER for the treatment of pain which is severe enough to require daily, around-the-clock, long-term opioid treatment.
TEVA : Summary for Teva Pharmaceutical Industries - Yahoo Finance
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||33.16 - 33.57|
|52 Week Range||33.16 - 64.31|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||22.20|
|Dividend & Yield||1.36 (3.99%)|
|1y Target Est||N/A|